Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01596751
Brief Title: Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer

First Submitted : May 7, 2012
First Submitted that Met QC Criteria : May 9, 2012
First Posted : May 11, 2012 (Estimate)

Results First Submitted : April 1, 2020
Results First Submitted that Met QC Criteria : May 1, 2020
Results First Posted : May 14, 2020

Last Update Submitted that Met QC Criteria : July 2, 2020
Last Update Posted : July 17, 2020